Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00883415 · ClinicalTrials.gov registry record
Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 20
- Enrollment target
NCT00883415: Completed study, sponsored by University of Maryland, Baltimore.
NCT00883415 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00883415 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study examines patients with chronic kidney disease-related anemia and measures changes in the metabolism of the heart using FDG/PET scanning, before and 6 months after their health-care provider has initiated anemia management therapy with the FDA-approved drug darbepoetin alfa (Aranesp), which is approved for chronic kidney disease-related anemia. The investigators hypothesize that the heart has abnormal metabolism with the anemia of chronic kidney disease but this improves after correction of this anemia with darbepoetin alfa.
Primary Outcome
Change in myocardial glucose uptake from baseline to 6 months expressed as change in micromol/min/100 g
Interventions
- DRUG Darbepoetin alfa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-11 |
What the finished NCT00883415 record still lists
NCT00883415 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Darbepoetin alfa is the first listed.
NCT00883415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00883415 about?
NCT00883415 is a clinical study titled "Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease". This study examines patients with chronic kidney disease-related anemia and measures changes in the metabolism of the heart using FDG/PET scanning, before and 6 months after their health-care provider has initiated anemia management therapy with the FDA-approved drug darbepoetin alfa (Aranesp), whic...
What is the current status of trial NCT00883415?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-05. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00883415?
The interventions under investigation include: Darbepoetin alfa (DRUG).
Who is sponsoring clinical trial NCT00883415?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia